Architectural T-Wave Analysis and Identification of On-Therapy Breakthrough Arrhythmic Risk in Type 1 and Type 2 Long-QT Syndrome

Circ Arrhythm Electrophysiol. 2017 Nov;10(11):e005648. doi: 10.1161/CIRCEP.117.005648.

Abstract

Background: Although the hallmark of long-QT syndrome (LQTS) is abnormal cardiac repolarization, there are varying degrees of phenotypic expression and arrhythmic risk. Our aim was to evaluate the performance of a morphological T-wave analysis program in defining breakthrough LQTS arrhythmic risk beyond the QTc value.

Methods and results: We analyzed 407 genetically confirmed patients with LQT1 (n=246; 43% men) and LQT2 (n=161; 41% men) over the mean follow-up period of 6.4±3.9 years. ECG analysis was conducted using a novel, proprietary T-wave analysis program. Time to a LQTS-associated cardiac event was analyzed using Cox proportional hazards regression methods. Twenty-three patients experienced ≥1 defined breakthrough cardiac arrhythmic events with 5- and 10-year event rates of 4% and 7%. Two independent predictors of future LQTS-associated cardiac events from the surface ECG were identified: left slope of T wave in lead V6 (hazard ratio=0.40 [0.24-0.69]; P<0.001) and T-wave center of gravity x axis (last 25% of wave) in lead I (hazard ratio=1.90 [1.21-2.99]; P=0.005), C statistic of 0.77 (0.65-0.89). When added to the QTc (C statistic 0.68 for QTc alone), discrimination improved to 0.78. Genotype analysis showed weaker association between these T-wave variables and LQT1-triggered events while these features were stronger in patients with LQT2 and significantly outperformed the QTc (C statistic, 0.82 [0.71-0.93]).

Conclusion: Detailed morphological analysis of the T wave provides novel insights into risk of breakthrough arrhythmic events in LQTS, particularly LQT2. This observation has the potential to guide clinical decision making and further refine risk stratification.

Keywords: arrhythmias, cardiac; death, sudden cardiac; electrocardiography; electrophysiology; long QT syndrome.

MeSH terms

  • Action Potentials
  • Adolescent
  • Adult
  • Anti-Arrhythmia Agents / therapeutic use*
  • Chi-Square Distribution
  • Child
  • Electrocardiography*
  • Female
  • Genetic Predisposition to Disease
  • Heart Conduction System / drug effects*
  • Heart Conduction System / physiopathology
  • Heart Rate / drug effects*
  • Humans
  • Kaplan-Meier Estimate
  • Long QT Syndrome / diagnosis*
  • Long QT Syndrome / drug therapy*
  • Long QT Syndrome / genetics
  • Long QT Syndrome / physiopathology
  • Male
  • Phenotype
  • Predictive Value of Tests
  • Proportional Hazards Models
  • Risk Assessment
  • Risk Factors
  • Romano-Ward Syndrome / diagnosis*
  • Romano-Ward Syndrome / drug therapy*
  • Romano-Ward Syndrome / genetics
  • Romano-Ward Syndrome / physiopathology
  • Time Factors
  • Treatment Outcome
  • Young Adult

Substances

  • Anti-Arrhythmia Agents

Supplementary concepts

  • Long Qt Syndrome 2